Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAS-trace 2 observational study of RAS/BRAF heterogeneity and anti-EGFR efficacy in advanced colorectal cancer
jRCT1050230049Recruiting
- Sponsor
- Hyogo Medical University
- Start
- Jun 2023
- Countries
- 1
01
Overview
Open-label, single-arm trial in colorectal cancer (CRC), sponsored by Hyogo Medical University. Primary endpoint: Progression-free survival in ctDNA RAS/BRAF wild and mutant. Started Jun 2023; status: recruiting.
02
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT1050230049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1050230049.